April 2024
1. CIMPEAN AM, Comsa S, Sturza A, Barb AC, et al
   Validation of Human Bone Marrow-derived Mesenchymal Stem Cells and MCF-7 Breast Cancer Cells Co-culture Using a 3D Perfused Biomimetic Microfluidic Platform.
   Anticancer Res. 2024;44:1441-1453.
   

   >> Share

   
   March 2024
2. KIM JS, Shin MJ, Lee SY, Choi SM, et al
   BBT-877, a Novel Autotaxin Inhibitor, Abrogates Drug Resistance in Epithelial Ovarian Cancer Stem Cells.
   Anticancer Res. 2024;44:1131-1142.
   

   >> Share

   
   January 2024
3. OZAKI A, Matsuda A, Maemura Y, Tada Y, et al
   Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy.
   Anticancer Res. 2024;44:37-47.
   

   >> Share

   
   November 2023
4. SHIOZAKI A, Kurashima K, Kudou M, Shimizu H, et al
   Cancer Stem Cells of Hepatocellular Carcinoma Are Suppressed by the Voltage-gated Calcium Channel Inhibitor Amlodipine.
   Anticancer Res. 2023;43:4855-4864.
   

   >> Share

   
   September 2023
5. UCHIDA M, Ishida S, Mochizuki E, Ozawa N, et al
   Improvement of Medication Guidance Sheet for Total Body Irradiation/Cyclophosphamide Followed by Allogeneic Hematopoietic Stem Cell Transplantation Based on Real Monitoring Data.
   Anticancer Res. 2023;43:4067-4075.
   

   >> Share

   
   June 2023
6. IGUCHI M, Yagyu S, Kambe K, Higashi M, et al
   Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy.
   Anticancer Res. 2023;43:2417-2424.
   

   >> Share

   
   
7. SIHOMBING AM, Murata S, Shimoji M, Miyake T, et al
   CD44-positive Cancer Stem-like Cells as a Potential Source of Peritoneal Metastasis After Surgery.
   Anticancer Res. 2023;43:2491-2500.
   

   >> Share

   
   May 2023
8. YAMANAKA T, Oshima T, Murayama D, Okamoto S, et al
   Clinical Significance of Cancer Stem Cell Markers in Primary and Metastatic Tissues in Patients With Breast Cancer.
   Anticancer Res. 2023;43:2145-2154.
   

   >> Share

   
   March 2023
9. NAKAGAWA-SAITO Y, Mitobe Y, Togashi K, Suzuki S, et al
   Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to Temozolomide.
   Anticancer Res. 2023;43:1131-1138.
   

   >> Share

   
   February 2023
10. SANO Y, Kuwabara N, Nakagawa S, Toda Y, et al
    Hypoxia-adapted Multiple Myeloma Stem Cells Resist gammadelta-T-Cell-mediated Killing by Modulating the Mevalonate Pathway.
    Anticancer Res. 2023;43:547-555.
    

    >> Share

    
    December 2022
11. STEINER N, Schober P, Willenbacher W, Kircher B, et al
    Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years.
    Anticancer Res. 2022;42:5825-5832.
    

    >> Share

    
    November 2022
12. KOCH K, Osswald L, Miller I, Braitsch K, et al
    Letermovir Prophylaxis for CMV Reactivation in Allogeneic Stem Cell Recipients: A Retrospective Single Center Analysis.
    Anticancer Res. 2022;42:5431-5441.
    

    >> Share

    
    September 2022
13. SUKPRASANSAP M, Chanvorachote P
    Evidence of Potential Plant-derived Compounds With Anticancer Effects on Lung Cancer: Clinical and Molecular Pharmacology Approaches.
    Anticancer Res. 2022;42:4247-4258.
    

    >> Share

    
    July 2022
14. ZHAO X, Ma B, Zhu H, Bai J, et al
    PI3K/Akt and Wnt/beta-catenin Signaling Cross-regulate NF-kappaB Signaling in TNF-alpha-induced Human Lgr5(+) Intestinal Stem Cells.
    Anticancer Res. 2022;42:3325-3340.
    

    >> Share

    
    April 2022
15. OHASHI K, Li TS, Miura S, Hasegawa Y, et al
    Biological Differences Between Ovarian Cancer-associated Fibroblasts and Contralateral Normal Ovary-derived Mesenchymal Stem Cells.
    Anticancer Res. 2022;42:1729-1737.
    

    >> Share

    
    March 2022
16. OKAMOTO A, Funakoshi Y, Oe M, Takai R, et al
    Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
    Anticancer Res. 2022;42:1199-1205.
    

    >> Share

    
    February 2022
17. COMSA S, Ceausu AR, Popescu R, Cimpean AM, et al
    Patterns of Tumor Vasculogenesis on a Chick Embryo Chorioallantoic Membrane In Vivo Model of Breast Cancer.
    Anticancer Res. 2022;42:877-883.
    

    >> Share

    
    January 2022
18. LI J, Persaud AK, Johnson JA, Sborov DW, et al
    A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy.
    Anticancer Res. 2022;42:385-395.
    

    >> Share

    
    December 2021
19. MOTOMURA H, Tamori S, Yatani MA, Namiki A, et al
    GLO 1 and PKClambda Regulate ALDH1-positive Breast Cancer Stem Cell Survival.
    Anticancer Res. 2021;41:5959-5971.
    

    >> Share

    
    November 2021
20. CIERPIKOWSKI P, Lis-Nawara A, Bar J
    SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:5405-5413.
    

    >> Share

    
    
21. TSOCHANTARIDIS I, Voulgaridou GP, Giatromanolaki A, Koukourakis MI, et al
    Profiling of Aldehyde Dehydrogenase Isoforms in In Vitro Formed Tumorspheres.
    Anticancer Res. 2021;41:5481-5488.
    

    >> Share

    
    October 2021
22. MIYAMOTO S, Fukui T, Horitani S, Tanimura Y, et al
    Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis.
    Anticancer Res. 2021;41:4789-4799.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share